Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Bioanalytical Systems, Inc.    BASI

BIOANALYTICAL SYSTEMS, INC.

(BASI)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Business Summary
Logo Bioanalytical Systems, Inc.
Bioanalytical systems, Inc. is an international contract research company providing drug discovery and development services and analytical instruments. The Company operates in two segments: contract research services and research products. The contract research services segment provides research and development support on a contract basis to pharmaceutical companies. The research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers, and medical research institutions. The Company supports the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates. The contract research services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing.

Number of employees : 322 people.
Sales per Business
20182019Delta
USD (in Million)%USD (in Million)%
Services22.4485.2%39.0589.5% +74.01%
Products3.9114.8%4.5710.5% +16.95%
Sales per region
20182019Delta
USD (in Million)%USD (in Million)%
United States22.2984.6%39.6390.9% +77.81%
Pacific Rim3.0711.7%2.415.5% -21.67%
Europe0.6702.5%1.222.8% +81.64%
Other North America0.1630.6%0.2180.5% +33.74%
Other0.1500.6%0.1400.3% -6.67%
Managers
NameAgeSinceTitle
Robert Leasure592019President, Chief Executive Officer & Director
Gregory C. Davis, Dr.662017Chairman
Beth A. Taylor532020Chief Financial Officer & Vice President-Finance
Richard Allen Johnson, Dr.732012Independent Director
Wendy Perrow612015Independent Director
R. Matthew Neff632017Independent Director
John E. Sagartz, Dr.552018Independent Director & Chief Strategy Officer
Candace A. Rohde Johnson-2017Director-InVivo Products & Services
Philip A. Downing-2019Senior Vice President-Preclinical Services
Michael Baim, Dr.-2018Senior Vice President-Analytical Operations
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 10,989,066 7,189,325 65.4% 0 0.0% 65.4%
Stock B 0 25 0 0.0% 0 0.0%
Shareholders
NameEquities%
Peter T. Kissinger 1,275,767 11.6%
estate of Hamot Seth W 636,621 5.79%
John E. Sagartz 634,232 5.77%
Kimberly L Sagartz 632,475 5.76%
Renaissance Technologies LLC 500,014 4.55%
The Vanguard Group, Inc. 449,627 4.09%
Healthinvest Partners AB 320,234 2.91%
Robert Leasure 186,549 1.70%
Monument Capital Management LLC 172,000 1.57%
Joe Flynn 127,514 1.16%
Company contact information
Bioanalytical Systems, Inc.
2701 Kent Avenue
West Lafayette, IN 47906

Phone : +1.765.463.4527
Fax : +1.765.497.1102
Web : http://www.basinc.com
Sector Biotechnology & Medical Research - NEC